Additionally, mutations in the microglial receptors CD33 and TREM2 have been associated with an increased risk of AD, and the proximity of AD risk loci to genes highly expressed in microglia suggests that neuroinflammation is critical to AD pathogenesis [64,65,66,67]. The gene discussed is CD33; the disease is Alzheimer disease.